Amgen's expenditure on research and development by category 2012-2018

This statistic shows the expenditure on research and development of biotech company Amgen in 2012 to 2018, sorted by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenses amounted to approximately four billion U.S. dollars in 2013. Of that amount, almost two billion U.S. dollars were spent on later stage clinical programs.

Amgen's expenditure on research and development in 2012 to 2018, by category

CategoryResearch and early pipelineLater stage clinical programsMarketed products
20121,1371,285958
20131,2331,950900
20141,2122,287798
20159971,8761,197
20161,0391,0541,747
20179728791,711
20181,2011,0341,502
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2012 to 2018

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Amgen"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.